ESMO 04/2017 Congress Report


Single articles:

What is new in surgery? Redefining current options
EGFR TKI therapy in specific populations and settings
"We are making steady progress toward better lung cancer control"
Taking anti-EGFR drug treatment further: later lines
Immunotherapy: novel biomarkers on the horizon & news from pivotal trials
Approaching squamous-cell carcinoma in a targeted manner
Malignant mesothelioma: recent data on nintedanib and checkpoint inhibitors
Chemotherapy: new approaches, new settings
Survival is the result of lung cancer screening


Download the 2017 WCLC congress report: